Abstract
Among the diverse fields of organ, cell, and tissue transplantation, the risk of infectious disease transmission from donor to recipient is common. Mitigating this threat requires robust donor assessment, accurate laboratory assays, and vigilance among clinicians caring for donors and recipients. In the past 10 years, reemergence and emergence of new pathogens, such as Zika virus and SARS-CoV-2, has added to an already lengthy list of infectious agents that need to be considered as part of surgical and medical transplantation risks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
